Connect with us

Centenunlimited News

Centenunlimited News

Nuggets’ Bol Bol Randomly Drug-Tested After Strong Performance vs. Wizards


Sports

Nuggets’ Bol Bol Randomly Drug-Tested After Strong Performance vs. Wizards

Mary Altaffer/Associated PressDenver Nuggets big man Bol Bol put on a show during Wednesday’s scrimmage against the Washington Wizards.And then he was randomly drug-tested.Mike Singer of the Denver Post noted the University of Oregon product had been scheduled for a random drug test after the game. In his team’s 89-82 victory, Bol dominated on his…

Nuggets’ Bol Bol Randomly Drug-Tested After Strong Performance vs. Wizards

Oregon center Bol Bol reacts after scoring a goal during the second half of an NCAA college basketball consolation game against Syracuse in the 2K Empire Classic, Friday, Nov. 16, 2018, at Madison Square Garden in New York. Oregon 80-65. (AP Photo/Mary Altaffer)

Mary Altaffer/Associated Press

Denver Nuggets big man Bol Bol put on a show during Wednesday's scrimmage against the Washington Wizards.

And then he was randomly drug-tested.

Mike Singer of the Denver Post noted the University of Oregon product had been scheduled for a random drug test after the game. In his team's 89-82 victory, Bol dominated on his way to 16 points, 10 rebounds and six blocks. The Sudan native did not play a game during the regular season because of a foot injury.

It wasn't just the stat line that stood out, but the versatility the 7'2″, 220-pound center showed as well.

The 2019 second-round pick drilled two three-pointers, protected the rim, cleaned the boards and even unleashed an impressive pass on a fast break.

Bol played just nine games at Oregon because of injuries, but the Nuggets may have another formidable big man alongside Nikola Jokic if Wednesday was a sign of things to come.

More showings like that may mean more random drug tests in the future for Bol as well.

Free Traffic Real Traffic At Your Finger Tips

Get Traffic With Zero Money Down

Join with bonus

Subscribe to Centenunlimited news

We hate SPAM and promise to keep your email address safe

Top Stories

To Top